NorthWest Biotherapeutics Inc (NWBO)

[ae kusterer]

dstock07734

Re: None

Saturday, July 20, 2024 11:34:16 AM

Post#
707229
of 707296
NCI researchers along with Dr. Liau and her colleagues did genetic profiling analysis on tissue samples from the p3 trial. In February the same group of NCI researchers just published a paper on long-term GBM survivors. The interesting part is that in the paper published in February NCI scientists defined long-term survivor as those who lived over three years while in the analysis which involves the p3 trial they chose those who lived over five years as long-term survivors. It is obvious that NCI set a higher bar to evaluate the results on the p3 trial.

Glioblastoma Molecular Characteristics and Immune Microenvironment Associated with Survival Outcomes in Patients Treated with Dendritic Cell Vaccination
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249282

Long-term survivors of glioblastoma: Tumor molecular, clinical, and imaging findings
https://academic.oup.com/noa/article/6/1/vdae019/7603818



https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172924113

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174700804